SCIENTURE HOLDINGS, INC. Payments to Acquire Equity Method Investments
SCIENTURE HOLDINGS, INC. (SCNX) reported Payments to Acquire Equity Method Investments of $250.00 thousand for the 12-month period ending 2019-12-31, per its 10-K filed 2021-03-29.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireEquityMethodInvestments · last filed 2021-03-29
- SCIENTURE HOLDINGS, INC. payments to acquire equity method investments for the quarter ending 2019-12-31 was $0.00.
- SCIENTURE HOLDINGS, INC. payments to acquire equity method investments for the quarter ending 2019-09-30 was $0.00.
- SCIENTURE HOLDINGS, INC. payments to acquire equity method investments for the quarter ending 2019-06-30 was $40.00K.
- SCIENTURE HOLDINGS, INC. payments to acquire equity method investments for the quarter ending 2019-03-31 was $210.00K.
- SCIENTURE HOLDINGS, INC. payments to acquire equity method investments for fiscal 2019 was $250.00K.
| Period end | Payments to Acquire Equity Method Investments 3 month | Payments to Acquire Equity Method Investments 6 month | Payments to Acquire Equity Method Investments 9 month | Payments to Acquire Equity Method Investments 12 month |
|---|---|---|---|---|
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-29 | $0.00 derived: sum of 2 quarters · filed 2021-03-29 | $40.00K derived: sum of 3 quarters · filed 2021-03-29 | $250.00K 10-K · filed 2021-03-29 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-26 | $40.00K derived: sum of 2 quarters · filed 2020-10-26 | $250.00K 10-Q · filed 2020-10-26 | |
| 2019-06-30 | $40.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-27 | $250.00K 10-Q · filed 2020-07-27 | ||
| 2019-03-31 | $210.00K 10-Q · filed 2020-05-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |